Deficits in the electroretinogram in neovascular age-related macular degeneration and changes during photodynamic therapy
Tóm tắt
To describe the deficits in four electroretinography (ERG) modalities in patients with neovascular age-related macular degeneration (AMD). To describe the changes in these parameters during a course of verteporfin photodynamic therapy (PDT). Pattern (PERG), multifocal (mfERG) (19 segment simplified test protocol), flash ERG and flicker ERG were performed in patients with active neovascular AMD before PDT and compared to fellow eye controls using paired t-tests. Changes in ERG parameters during the 12 month treatment course were visualised using 95% confidence intervals of the median difference. The statistical significance of any changes was quantified using Wilcoxon signed ranks tests. Fifty patients were recruited and followed. At presentation all ERG amplitudes were reduced with greater reductions in focal as opposed to global test protocols (P < 0.05). Over the 12 month course of PDT, PERG P50 amplitude showed a general downward trend and latency remained unchanged. mfERG p1 amplitude density showed an upward trend at six months before returning to baseline by 12 months. mfERG ring 2 amplitude density was significantly increased at 12 months compared to baseline (P = 0.010). Flicker ERG latency was significantly increased at six months compared to baseline (P = 0.015). The simplified mfERG protocol was tolerated by this patient group, however, they found the full test protocol demanding. Large deficits in the retinal ERG function occur in neovascular AMD and involve retinal locations adjacent to as well as overlying choroidal neovascularisation (CNV). After PDT there is an improvement in electro-retinal function in retinal locations overlying the CNV.
Tài liệu tham khảo
Rubin GS, Bressler NM (2002) Effects of Verteporfin therapy on contrast sensitivity – Results from the treatment of age-related macular degeneration with Photodynamic Therapy (TAP) investigation – TAP Report No. 4. Retina 22:536–544
TAP Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin-TAP Report 1. Arch Ophthalmol 117:1329–1345
TAP Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with Verteporfin-TAP Report 2. Arch Ophthalmol 119:198–207
TAP Study Group (2002) Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with Verteporfin-TAP Report 3. Arch Ophthalmol 120:1443–1454
TAP Study Group (2002) Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with Verteporfin-TAP Report 5. Arch Ophthalmol 120:1307–1314
TAP Study Group (2003) Improvement after Verteporfin therapy. Arch Ophthalmol 121:415
Celesia GG, Cone S, Kaufman D (1986) Effects of age and sex on pattern electroretinograms and and visual evoked potentials. Electroenceph Clin Neurophysiol 64:29
Jackson GR, Ortega JD, Girkin C et al (2002) Ageing-related changes in the multifocal electroretinogram. J Opt Soc Am A 19:185–189
Jackson GR, Leon-Ortega J, Rosenstiel CE et al (2001) Age-related changes in the multifocal electroretinogram of central vision. Invest Ophthalmol Vis Sci 42(4):381
Wright C, William D, Drasdo N et al (1985) The influence of age on the electroretinogram and visual evoked potential. Doc Ophthalmol 59:365–384
Seiple W, Vajaranant T, Szlyk J et al (2003) Multifocal electroretinography as a function of age: the importance of normative values for older adults. Invest Ophthalmol Vis Sci 44:1783–1792
Heinemann-Vernaleken B, Palmowski A, Allgayer R et al (2001) Comparison of different high resolution multifocal electroretinogram recordings in patients with age-related maculopathy. Graef Arch Clin Exp Ophthalmol 239:556–561
Huang S, Wu D, Jiang F et al (2001) The multifocal electroretinogram in age-related maculopathies. Doc Ophthalmol 101:115–124
Li J, Tso MOM, Lam TT (2001) Reduced amplitude and delayed latency in foveal response of multifocal electroretinogram in early age related macular degeneration. Br J Ophthalmol 85(3):287–290
Jurklies B, Weismann M, Husing J et al (2002) Monitoring retinal function in neovascular maculopathy using multifocal electroretinography- early and long-term correlation with clinical findings. Graef Arch Clin Exp Ophthalmol 240:244–264
Moschos MM, Panayotidis D, Theodossiadis G et al (2004) Assessment of macular function by multifocal electroretinogram in age-related macular degeneration before and after photodynamic therapy. J Fr Ophthalmol 27:1001–1006
Palmowski AM, Allgayer R, Heinemann-Vernaleken B et al (2002) Influence of photodynamic therapy in choroidal neovascularization on focal retinal function assessed with the multifocal electroretinogram and perimetry. Ophthalmology 109:1788–1792
Jiang L, Jin C, Wen F et al (2003) The changes of multifocal electroretinography in the early stage of photodynamic therapy for choroidal neovascularisation. Doc Ophthalmol 107(2):165–170
Lai TYY, Chan W, Lam D (2004) Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy. Am J Ophthalmol 137:826–833
Neveu MM, Tufail A, Dowler JG, Holder GE (2006) A comparison of pattern and multifocal electroretinography in the evaluation of age-related macular degeneration and its treatment with photodynamic therapy. Doc Ophthalmol 113(2):71–81
Michels S, Schmidt-Erfurth U (2003) Sequence of early vascular events after photodynamic therapy. Invest Ophthalmol Vis Sci 44:2147–2154
Marmor M, Hood DC, Keating D et al (2003) Guidelines for basic multifocal electroretinography (mfERG). Doc Ophthalmol 106:105–115
Hagan RP, Fisher AC, Brown MC (2006) Examination of short binary sequences for mfERG recording. Doc Ophthalmol 113(1):21–27
Heinemann-Vernaleken B, Palmowski AM, Allgayer R, Jurklies B (1999) Comparison of different high resolution multifocal ERG (MF-ERG) recordings in age related macular degeneration (AMD). Invest Ophthalmol Vis Sci 40(4):3773
Jurklies B, Weismann M, Bornfeld N (2000) Multifocal ERG in age-related macular degeneration with hard and soft drusen. Invest Ophthalmol Vis Sci 41(4):4749
Jurklies B, Weismann M, Bornfeld N (1999) Multifocal electretinography in age-related macular degeneration- changes in amplitude of the 1st order kernel. Invest Ophthalmol Vis Sci 40(4):1668
Parks S, Keating D, Evans AL (2000) Peripheral retinal dysfunction in Age-related macular degeneration. Invest Ophthalmol Vis Sci 41(4):847
Holopigian K, Seiple W, Greenstein V et al (1997) Relative effects of aging and age-related macular degeneration on peripheral visual function. Optom Vis Sci 74:152–159
Schmidt-Erfurth UM, Elsner H, Terai N et al (2004) Effects of verteporfin on central visual field function. Ophthalmology 111:931–939
Jurklies B, Sutter E (2001) Reply to G. Rudolph and P. Kalpadakis: the role of fixation for reliable mfERG results. Graef Arch Clin Exp Ophthalmol 240:876
Rudolph G, Kalpadakis P (2002) The role of fixation for reliable mfERG results. Graef Arch Clin Exp Ophthalmol 240:874–875
Elsner H, Schmidt-Erfurth UM (2004) Analysis of fixation results after photodynamic therapy of subfoveal choroidal neovascularisations. Ophthalmologe 99:620–624
Mennel S, Meyer CH (2005) Transient visual disturbance after photodynamic therapy. Am J Ophthalmol 139:748–749
Rogers AH, Martidis A, Greenberg PB et al (2002) Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. Am J Ophthalmol 134:566–576